Femasys FEMY
NASDAQ FEMY
$2.19 +0.10 (+4.78%)
As of: Sep 30, 2026 · 2:55 PM EDT

Femasys (FEMY) Convertible Debt (2023 - 2025)

Updated

Femasys (FEMY) recorded Convertible Debt of $3.18 million in Q4 2025.

Analysis

Femasys (FEMY) Convertible Debt (2023 - 2025) Analysis & Trends

Starting with Q4 2023, Femasys' Convertible Debt history includes 5 quarters.

  • Across earlier years, Convertible Debt came in at $4.26 million in FY2023.
  • The Q4 2025 figure is the highest quarterly Convertible Debt since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Femasys 6.32 Mn -14.34 Mn 189,391.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.18 Mn
Sep 30, 2024 5.07 Mn
Jun 30, 2024 4.76 Mn
Mar 31, 2024 4.47 Mn
Dec 31, 2023 4.26 Mn
API Access

Femasys Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=FEMY&period=max&api_key=YOUR_API_KEY